529 related articles for article (PubMed ID: 23410183)
1. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
[TBL] [Abstract][Full Text] [Related]
2. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
Garris DR; Garris BL
Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
Lim M; Park L; Shin G; Hong H; Kang I; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
[TBL] [Abstract][Full Text] [Related]
4. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF
Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
Ladefoged M; Buschard K; Hansen AM
APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
[TBL] [Abstract][Full Text] [Related]
7. Elovl6 Deficiency Improves Glycemic Control in Diabetic
Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
[TBL] [Abstract][Full Text] [Related]
8. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
9. Reduced proliferation and a high apoptotic frequency of pancreatic beta cells contribute to genetically-determined diabetes susceptibility of db/db BKS mice.
Puff R; Dames P; Weise M; Göke B; Seissler J; Parhofer KG; Lechner A
Horm Metab Res; 2011 May; 43(5):306-11. PubMed ID: 21412687
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
Garris DR; Garris BL
Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
12. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated β-cell dysfunction.
Tian YF; Chang WC; Loh CH; Hsieh PS
Life Sci; 2014 Oct; 116(1):51-8. PubMed ID: 25123537
[TBL] [Abstract][Full Text] [Related]
13. Restoration of
D'souza AM; Kieffer TJ
Mol Metab; 2017 Jun; 6(6):585-593. PubMed ID: 28580288
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese mice.
Hogh KL; Uy CE; Asadi A; Baker RK; Riedel MJ; Gray SL
Exp Physiol; 2013 Feb; 98(2):564-75. PubMed ID: 23042378
[TBL] [Abstract][Full Text] [Related]
16. A compound (DW1182v) protecting high glucose/palmitate-induced glucolipotoxicity to INS-1 beta cells preserves islet integrity and improves hyperglycemia in obese db/db mouse.
Lee SJ; Choi SE; Hwang YC; Jung IR; Yi SA; Jung JG; Ku JM; Jeoung K; Han SJ; Kim HJ; Kim DJ; Lee KW; Kang Y
Eur J Pharmacol; 2012 Dec; 696(1-3):187-93. PubMed ID: 23026370
[TBL] [Abstract][Full Text] [Related]
17. PI3Kγ ablation does not promote diabetes in
Breasson L; Sardi C; Becattini B; Zani F; Solinas G
FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
[TBL] [Abstract][Full Text] [Related]
18. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
[TBL] [Abstract][Full Text] [Related]
19. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
20. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
